세계의 세포배양 시장 : 제품별, 용도별, 최종사용자별, 지역별 - 예측(-2029년)

Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) - Global Forecast to 2029

US $ 4,950 ￦ 6,814,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,155,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,220,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,767,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세포배양 시장 규모는 2024년 309억 달러에서 2029년 579억 달러에 달할 것으로 예상되며, 2024년부터 2029년까지 예측 기간 동안 13.4%의 CAGR을 기록할 것으로 예상됩니다.

이 시장의 성장은 세포 생물학 분야의 연구 투자 및 자금 지원 증가에 기인합니다. 암과 같은 만성 질환의 발병률이 증가하면서 조직공학 및 재생의료와 같은 첨단 치료법에 대한 수요가 증가하고 있습니다. 이러한 추세는 향후 몇 년 동안 세포배양 시장의 성장을 촉진할 것으로 예상됩니다.

조사 범위
조사 대상 연도	2022-2029년
기준 연도	2023년
예측 기간	2024-2029년
검토 단위	금액(10억 달러)
부문	제품별, 용도별, 최종사용자별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

감염병의 확산으로 백신, 단클론항체, 치료용 단백질 등 바이오의약품에 대한 수요가 증가하면서 세포배양 바이오의약품 생산 시장의 성장을 촉진하고 있습니다.

2023년 북미 세포배양 시장은 미국이 주도했습니다. 세계 최대 바이오의약품 시장으로서 바이오의약품 연구와 투자에 중점을 둔 미국은 두드러진 위치를 차지하고 있습니다. 또한 미국에는 하버드대학교, 스탠포드대학교, 매사추세츠공과대학(MIT) 등 유명한 학술 연구기관이 있으며, 신약개발 및 생명공학 등 생명과학 분야에서 획기적인 연구를 수행하는 것으로 알려져 세포배양 기술을 많이 사용함으로써 시장 확대를 촉진하고 있습니다. 또한, 조직공학 및 재생의료 연구개발에 대한 투자가 증가하고 있는 것도 세포배양 시장 성장에 기여하고 있습니다.

이 보고서는 세계 세포배양 시장을 조사하여 제품별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 정리하여 전해드립니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

• 소개
• 시장 역학
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 가격 분석
• 기술 분석
• 거래 데이터
• 특허 분석
• 밸류체인 분석
• 공급망 분석
• 생태계 분석
• Porter's Five Forces 분석
• 규제 상황
• 2024-2025년의 주요 회의와 이벤트
• 주요 이해관계자와 구입 기준
• 투자와 자금 조달 시나리오

제6장 세포배양 시장, 제품별

• 소개
• 소모품
• 장비

제7장 세포배양 시장, 용도별

• 소개
• 바이오의약품 제조
• 진단
• 조직공학과 재생의료
• 의약품 스크리닝과 개발
• 기타

제8장 세포배양 시장, 최종사용자별

• 소개
• 제약회사·바이오테크놀러지 기업
• 병원·진단 검사실
• 연구기관 및 학술기관
• 기타

제9장 세포배양 시장, 지역별

• 소개
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제10장 경쟁 상황

• 소개
• 주요 진출 기업이 채용한 전략
• 수익 분배 분석
• 시장 점유율 분석
• 브랜드/제품 비교 분석
• 기업 평가 매트릭스 : 주요 진출 기업
• 기업 평가 매트릭스 : 스타트업/중소기업
• 세포배양 벤더의 평가와 재무 지표
• 경쟁 시나리오

제11장 기업 개요

• 소개
• 주요 진출 기업
  • THERMO FISHER SCIENTIFIC INC.
  • DANAHER CORPORATION
  • MERCK KGAA
  • SARTORIUS AG
  • CORNING INCORPORATED
  • FUJIFILM HOLDINGS CORPORATION
  • BD
  • EPPENDORF SE
  • LONZA
  • GETINGE AB
  • AGILENT TECHNOLOGIES, INC.
  • HIMEDIA LABORATORIES
  • BIO-TECHNE
• 기타 기업
  • MILTENYI BIOTEC
  • STEMCELL TECHNOLOGIES
  • SOLIDA BIOTECH GMBH
  • CAISSON LABS INC.
  • PROMOCELL GMBH
  • INVIVOGEN
  • PAN-BIOTECH
  • CELLEXUS
  • MEISSNER FILTRATION PRODUCTS, INC.
  • ADOLF KUHNER AG
  • ADVANCION CORPORATION
  • BIOSPHERIX, LTD.

제12장 부록

ksm

영문 목차

영문목차

The cell culture market is projected to reach USD 57.9 billion by 2029 from an estimated USD 30.9 billion in 2024, at a CAGR of 13.4% during the forecast period of 2024 to 2029. The growth of this market can be attributed to growing investments and fundings for research in the field of cell biology. The rising incidence of chronic diseases such as cancer is boosting the demand for advanced therapies such as tissue engineering, and regenerative medicine. This trend is expected to drive the growth of the cell culture market in the coming years.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD) Billion
Segments	Product, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

"The biopharmaceutical production segment accounted for the largest share of by application segment in 2023."

In 2023, the biopharmaceutical production segment accounted for the largest share of by application segment in the global cell culture market. Biopharmaceutical production segment is further categorized into vaccine production, monoclonal antibody production, and other therapeutic protein production. The growing prevalence of infectious diseases is boosting the demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and therapeutic proteins, resulting to promote the growth of biopharmaceutical production in cell culture market.

"The US will continue to dominate the cell culture market during the forecast period of 2024-2029."

In 2023, the cell culture market in North America was led by the US. As the world's largest biopharmaceutical market with a strong emphasis on research and investment in biopharmaceuticals, the US holds a prominent position. Moreover, the country hosts renowned academic research institutions such as Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT), renowned for their groundbreaking work in life sciences, including drug discovery and biotechnology, which extensively employ cell culture techniques, thereby fuelling market expansion. Furthermore, increasing investments in tissue engineering and regenerative medicine R&D are contributing to the growth of the cell culture market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
• By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• Merck KGaA (Germany)
• Corning Incorporated (US)
• FUJIFILM Holdings Corporation (Japan)
• BD (US)
• Eppendorf SE (Germany)
• Lonza (Switzerland)
• Getinge AB (Sweden)
• Agilent Technologies, Inc. (US)
• HiMedia Laboratories (India)
• Miltenyi Biotec (Germany)
• STEMCELL Technologies (Canada)
• Solida Biotech GmbH (Germany)
• Caisson Labs (US)
• PromoCell GmbH (Germany)
• InvivoGen (France)
• PAN-Biotech (Germany)
• Cellexus (Scotland)
• Meissner Filtration Products Inc. (US)
• Adolf Kuhner AG (Switzerland)
• Bio-Techne (US)
• Advancion Corporation (US)
• BioSpherix, Ltd. (US)

Research Coverage:

This research report categorizes the cell culture market by product ((equipment (bioreactors, storage equipment, and other equipment), consumables (sera, media, reagents, vessels, and accessories)), by application (biopharmaceutical production (vaccine production, monoclonal antibody production, and other therapeutic protein production), diagnostics, tissue engineering & regenerative medicine (cell & gene therapy and other tissue engineering & regenerative medicine applications), drug screening & development, and other applications), by end user (pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell culture market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the cell culture market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (increasing prevalence of infectious diseases, rising adoption of single-use technologies, and growing strategic alliances for the development of advanced therapy medicine products), restraints (high cost of cell biology research and limitations regarding production of high density cell culture), opportunities (growing opportunities in emerging economies, rising demand for 3D cell culture), and Challenges (ethical concern regarding cell usage) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the cell culture market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell culture market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf Kuhner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US), among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 REGIONS COVERED
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY
  • 1.5.1 VALUE UNIT
  • 1.5.2 VOLUME UNIT
• 1.6 STAKEHOLDERS
• 1.7 LIMITATIONS
• 1.8 SUMMARY OF CHANGES
• 1.9 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MARKET
• 2.2 MARKET ESTIMATION METHODOLOGY
  • FIGURE 3 CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • 2.2.1 BOTTOM-UP APPROACH
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023)
  • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.2.3 TOP-DOWN APPROACH
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• 2.3 MARKET GROWTH RATE PROJECTIONS
  • FIGURE 8 CELL CULTURE MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RISK ANALYSIS
• 2.7 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 10 CELL CULTURE MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 11 CELL CULTURE MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 12 CELL CULTURE MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 GEOGRAPHICAL SNAPSHOT OF CELL CULTURE MARKET

4 PREMIUM INSIGHTS

• 4.1 CELL CULTURE MARKET OVERVIEW
  • FIGURE 14 INCREASING APPROVALS AND LAUNCHES OF BIOLOGICAL DRUGS TO SUPPORT MARKET GROWTH
• 4.2 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT AND COUNTRY (2023)
  • FIGURE 15 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023
• 4.3 CELL CULTURE MARKET SHARE, BY APPLICATION, 2023
  • FIGURE 16 BIOPHARMACEUTICAL PRODUCTION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
• 4.4 CELL CULTURE MARKET SHARE, BY END USER, 2023
  • FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED END-USER MARKET IN 2023
• 4.5 CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 19 CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 2 CELL CULTURE MARKET: IMPACT ANALYSIS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing support and funding from government and private organizations for cell-based research
  • TABLE 3 NIH FUNDING FOR STEM CELL-BASED RESEARCH, 2020-2024 (USD MILLION)
  • TABLE 4 FUNDING INVESTMENTS IN CELL & GENE THERAPY
    • 5.2.1.2 Emerging cell culture technologies for production of cell-based viral vaccines
    • 5.2.1.3 Growing popularity of monoclonal antibodies and biosimilars
  • TABLE 5 COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2023
  • FIGURE 20 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU (2012-2023)
  • FIGURE 21 NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED (2015-2024)
    • 5.2.1.4 Adoption of single-use technologies
    • 5.2.1.5 Growing focus of key players on product launches
    • 5.2.1.6 Growth in advanced therapy medicinal products
  • FIGURE 22 CLINICAL TRIALS OVERVIEW OF TISSUE-ENGINEERED PRODUCTS (2019-2023)
    • 5.2.1.7 Increasing incidence of infectious diseases
  • FIGURE 23 GLOBAL HIV EPIDEMIC, 2022
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of cell biology research
    • 5.2.2.2 Limitations in producing high-density cell cultures
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising demand for 3D cell cultures
    • 5.2.3.2 Emerging economies offer lucrative growth opportunities
  • TABLE 6 ASIA PACIFIC PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2023
    • 5.2.3.3 Increasing focus on next-generation therapeutics
  • FIGURE 24 RSV VACCINE AND MAB SNAPSHOT (AS OF JANUARY 2024)
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Disposal of plastic consumables
  • TABLE 7 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
    • 5.2.4.2 Ethical concerns related to cell usage
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE OF CELL CULTURE EQUIPMENT AND CONSUMABLES
  • TABLE 8 AVERAGE SELLING PRICE RANGE OF CELL CULTURE EQUIPMENT AND CONSUMABLES, BY KEY PLAYER
  • 5.4.2 AVERAGE SELLING PRICE OF CELL CULTURE PRODUCTS, BY REGION
  • TABLE 9 AVERAGE SELLING PRICE RANGE OF SINGLE-USE ASSEMBLIES, BY REGION
  • TABLE 10 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000L IN DEVELOPED AND DEVELOPING COUNTRIES (2023)
• 5.5 TECHNOLOGY ANALYSIS
  • 5.5.1 KEY TECHNOLOGIES
    • 5.5.1.1 Single-use technology
  • TABLE 11 ADVANTAGES OF SINGLE-USE AND STAINLESS-STEEL BIOREACTORS
    • 5.5.1.2 Flow cytometry
    • 5.5.1.3 Microscopy
  • 5.5.2 COMPLEMENTARY TECHNOLOGIES
    • 5.5.2.1 High-throughput screening
    • 5.5.2.2 Mass spectrometry
  • 5.5.3 ADJACENT TECHNOLOGIES
    • 5.5.3.1 Microfluidics and organ-on-a-chip
  • TABLE 12 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE
    • 5.5.3.2 3D bioprinting
• 5.6 TRADE DATA
  • TABLE 13 IMPORT VALUE FOR CELL CULTURE MEDIA, 2018-2022 (USD THOUSAND)
  • TABLE 14 EXPORT VALUE FOR CELL CULTURE MEDIA, 2018-2022 (USD THOUSAND)
  • TABLE 15 IMPORT VOLUME FOR CELL CULTURE MEDIA, 2018-2022 (TONS)
  • TABLE 16 EXPORT VOLUME FOR CELL CULTURE MEDIA, 2018-2022 (TONS)
• 5.7 PATENT ANALYSIS
  • 5.7.1 METHODOLOGY
  • 5.7.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
  • TABLE 17 PATENTS FILED, 2014-2024
  • 5.7.3 INNOVATION AND PATENT APPLICATIONS
  • FIGURE 26 TOTAL NUMBER OF PATENTS GRANTED, 2014-2024
  • 5.7.4 TOP APPLICANTS
  • FIGURE 27 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2024
  • TABLE 18 TOP 20 PATENT OWNERS IN CELL CULTURE, 2014-2024
  • TABLE 19 INDICATIVE LIST OF PATENTS IN CELL CULTURE MARKET, 2022-2024
• 5.8 VALUE CHAIN ANALYSIS
  • FIGURE 28 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTE MAXIMUM VALUE
• 5.9 SUPPLY CHAIN ANALYSIS
  • FIGURE 29 CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS
• 5.10 ECOSYSTEM ANALYSIS
  • FIGURE 30 CELL CULTURE MARKET: ECOSYSTEM ANALYSIS
  • 5.10.1 CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS
  • TABLE 20 CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS
  • 5.10.2 CELL CULTURE MARKET: ROLE OF PRODUCT PROVIDERS
  • TABLE 21 CELL CULTURE MARKET: ROLE OF PRODUCT PROVIDERS
  • 5.10.3 CELL CULTURE MARKET: ROLE OF END USERS
  • TABLE 22 CELL CULTURE MARKET: ROLE OF END USERS
  • 5.10.4 CELL CULTURE MARKET: ROLE OF REGULATORY AUTHORITIES
  • TABLE 23 CELL CULTURE MARKET: ROLE OF REGULATORY AUTHORITIES
• 5.11 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 24 CELL CULTURE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.11.1 THREAT OF NEW ENTRANTS
  • 5.11.2 THREAT OF SUBSTITUTES
  • 5.11.3 BARGAINING POWER OF SUPPLIERS
  • 5.11.4 BARGAINING POWER OF BUYERS
  • 5.11.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.12 REGULATORY LANDSCAPE
  • 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 26 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 27 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 28 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12.2 REGULATORY SCENARIO
  • TABLE 29 CELL CULTURE MARKET: REGULATORY GUIDELINES
• 5.13 KEY CONFERENCES & EVENTS, 2024-2025
  • TABLE 30 CELL CULTURE MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024-2025
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL CULTURE PRODUCTS
  • 5.14.2 BUYING CRITERIA FOR CELL CULTURE
  • FIGURE 32 KEY BUYING CRITERIA FOR END USERS
  • TABLE 31 BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER
• 5.15 INVESTMENT AND FUNDING SCENARIO

6 CELL CULTURE MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 32 CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• 6.2 CONSUMABLES
  • TABLE 33 CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 34 CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 MIDDLE EAST: CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.1 SERA, MEDIA, AND REAGENTS
  • TABLE 41 SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 42 SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 43 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.1 Media
  • TABLE 49 MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 50 MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 MEDIA MARKET, BY REGION, 2022-2029 (MILLION LITERS)
  • TABLE 52 NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 EUROPE: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 MIDDLE EAST: MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 57 GCC COUNTRIES: MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.1.1 Serum-free media
      • 6.2.1.1.1.1 Serum-free media to hold largest market share
  • TABLE 58 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 59 SERUM-FREE MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 MIDDLE EAST: SERUM-FREE MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 65 GCC COUNTRIES: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.1.2 Classical media & salts
      • 6.2.1.1.2.1 Increased usage of classical media and salts for efficient and scalable vaccine production to drive segment growth
  • TABLE 66 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
  • TABLE 67 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 MIDDLE EAST: CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 73 GCC COUNTRIES: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.1.3 Stem cell culture media
      • 6.2.1.1.3.1 Funding and grants for stem cell-based research and therapies to drive market
  • TABLE 74 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 75 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 MIDDLE EAST: STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 81 GCC COUNTRIES: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.1.4 Chemically defined media
      • 6.2.1.1.4.1 Rising need for reproducibility, regulatory compliance, and precise control in cell culture systems to support growth
  • TABLE 82 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 83 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 MIDDLE EAST: CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 89 GCC COUNTRIES: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.1.5 Specialty media
      • 6.2.1.1.5.1 Suitability for use in selective cell types in bioprocessing and biomanufacturing industries to boost adoption
  • TABLE 90 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 91 SPECIALTY MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 MIDDLE EAST: SPECIALTY MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 97 GCC COUNTRIES: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.1.6 Other media
  • TABLE 98 OTHER MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 99 OTHER MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 EUROPE: OTHER MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: OTHER MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 MIDDLE EAST: OTHER MEDIA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 105 GCC COUNTRIES: OTHER MEDIA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2 Reagents
  • TABLE 106 REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 108 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 113 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.1 Growth factors
      • 6.2.1.2.1.1 Growth factors to hold largest share of reagents market
  • TABLE 114 GROWTH FACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 EUROPE: GROWTH FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: GROWTH FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 LATIN AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 119 MIDDLE EAST: GROWTH FACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 120 GCC COUNTRIES: GROWTH FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.2 Supplements
      • 6.2.1.2.2.1 Acquisitions and expansions by key cell culture vendors to drive growth
  • TABLE 121 SUPPLEMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 EUROPE: SUPPLEMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: SUPPLEMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 LATIN AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 MIDDLE EAST: SUPPLEMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 127 GCC COUNTRIES: SUPPLEMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.3 Buffers & chemicals
      • 6.2.1.2.3.1 Wide usage in cell cultures to promote market growth
  • TABLE 128 BUFFERS & CHEMICALS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 129 NORTH AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 130 EUROPE: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 LATIN AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 MIDDLE EAST: BUFFERS & CHEMICALS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 134 GCC COUNTRIES: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.4 Cell dissociation reagents
      • 6.2.1.2.4.1 Ability to efficiently and gently detach adherent cells from culture surfaces to boost demand for dissociation reagents
  • TABLE 135 CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 136 NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 EUROPE: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 139 LATIN AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 MIDDLE EAST: CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 141 GCC COUNTRIES: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.5 Balanced salt solutions
      • 6.2.1.2.5.1 Ability to maintain optimal physiological conditions for cell growth and experimentation to drive segment growth
  • TABLE 142 BALANCED SALT SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 143 NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 144 EUROPE: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 MIDDLE EAST: BALANCED SALT SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 148 GCC COUNTRIES: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.6 Attachment & matrix factors
      • 6.2.1.2.6.1 Rising adoption of 3D cell culture models to support market growth
  • TABLE 149 ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 150 NORTH AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 EUROPE: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 LATIN AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 MIDDLE EAST: ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 155 GCC COUNTRIES: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.7 Antibiotics/Antimycotics
      • 6.2.1.2.7.1 Risk of contamination to make use of antibiotics/antimycotics essential
  • TABLE 156 ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 157 NORTH AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 EUROPE: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 LATIN AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 MIDDLE EAST: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 162 GCC COUNTRIES: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.8 Cryoprotective reagents
      • 6.2.1.2.8.1 Ability to preserve cell viability during freezing and thawing to boost demand
  • TABLE 163 CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 164 NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 165 EUROPE: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 LATIN AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 MIDDLE EAST: CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 169 GCC COUNTRIES: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.9 Contamination detection kits
      • 6.2.1.2.9.1 Rapid identification of microbial contaminants to drive usage of contamination detection kits
  • TABLE 170 CONTAMINATION DETECTION KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 171 NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 EUROPE: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 174 LATIN AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 175 MIDDLE EAST: CONTAMINATION DETECTION KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 176 GCC COUNTRIES: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.2.10 Other reagents
  • TABLE 177 OTHER REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 178 NORTH AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 EUROPE: OTHER REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: OTHER REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 181 LATIN AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 182 MIDDLE EAST: OTHER REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: OTHER REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.3 Sera
  • TABLE 184 SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 SERA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 186 NORTH AMERICA: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 187 EUROPE: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 189 LATIN AMERICA: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 MIDDLE EAST: SERA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 191 GCC COUNTRIES: SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.3.1 Fetal bovine sera
      • 6.2.1.3.1.1 Fetal bovine sera to hold largest share
  • TABLE 192 FETAL BOVINE SERA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 193 NORTH AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 194 EUROPE: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 196 LATIN AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 MIDDLE EAST: FETAL BOVINE SERA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 198 GCC COUNTRIES: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.3.2 Adult bovine sera
      • 6.2.1.3.2.1 Cost-effectiveness and use as a biochemical reagent in IVD to support adoption
  • TABLE 199 ADULT BOVINE SERA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 200 NORTH AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 201 EUROPE: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 202 ASIA PACIFIC: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 203 LATIN AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 204 MIDDLE EAST: ADULT BOVINE SERA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 205 GCC COUNTRIES: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1.3.3 Other animal sera
  • TABLE 206 OTHER ANIMAL SERA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 207 NORTH AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 208 EUROPE: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 210 LATIN AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 211 MIDDLE EAST: OTHER ANIMAL SERA MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 212 GCC COUNTRIES: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.2 VESSELS
  • TABLE 213 VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 VESSELS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 215 NORTH AMERICA: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 216 EUROPE: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST: VESSELS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 220 GCC COUNTRIES: VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2.1 Cell factory systems/cell stacks
      • 6.2.2.1.1 Efficient and scalable solutions for large-scale expansion to drive end-user adoption
  • TABLE 221 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 222 NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 223 EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 225 LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 226 MIDDLE EAST: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2.2 Roller/roux bottles
      • 6.2.2.2.1 Scalability, cost-effectiveness, and ease of handling to support growth
  • TABLE 228 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 229 NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 230 EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 231 ASIA PACIFIC: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 232 LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 233 MIDDLE EAST: ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 234 GCC COUNTRIES: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2.3 Flasks
      • 6.2.2.3.1 Advancements in cell culture flasks to boost segment growth
  • TABLE 235 FLASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 236 NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 237 EUROPE: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 239 LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 240 MIDDLE EAST: FLASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 241 GCC COUNTRIES: FLASKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2.4 Multiwell plates
      • 6.2.2.4.1 Increased adoption of multiwell plates to drive market
  • TABLE 242 MULTIWELL PLATES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 243 NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 244 EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 246 LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 247 MIDDLE EAST: MULTIWELL PLATES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 248 GCC COUNTRIES: MULTIWELL PLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2.5 Petri dishes
      • 6.2.2.5.1 Ease of use to drive demand
  • TABLE 249 PETRI DISHES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 250 NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 251 EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 252 ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 253 LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 254 MIDDLE EAST: PETRI DISHES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 255 GCC COUNTRIES: PETRI DISHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.3 ACCESSORIES
    • 6.2.3.1 Reduced preparation time and equipment performance improvements to drive market
  • TABLE 256 ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 257 NORTH AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 258 EUROPE: ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 260 LATIN AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 261 MIDDLE EAST: ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.3 EQUIPMENT
  • TABLE 263 EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 265 NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 266 EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 267 ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 268 LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 269 MIDDLE EAST: EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 270 GCC COUNTRIES: EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.1 BIOREACTORS
  • TABLE 271 BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 273 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 274 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 276 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 277 MIDDLE EAST: BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

• 6.3.1.1 Conventional bioreactors
  • 6.3.1.1.1 Utilization in large-scale manufacturing of drugs to drive market
• TABLE 279 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 280 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 281 EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 282 ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 283 LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 284 MIDDLE EAST: CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 285 GCC COUNTRIES: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.1.2 Single-use bioreactors
    • 6.3.1.2.1 Lower operational costs and increased flexibility to boost demand
• TABLE 286 LIST OF COMMERCIALLY AVAILABLE SINGLE-USE BIOREACTORS, BY KEY PLAYER
• TABLE 287 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 288 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 289 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 290 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 291 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 292 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 293 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.3.2 STORAGE EQUIPMENT
• TABLE 294 STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 295 STORAGE EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 296 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 297 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 298 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 299 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 300 MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 301 GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.2.1 Refrigerators & freezers
    • 6.3.2.1.1 Increasing need for storage solutions to propel market
• TABLE 302 REFRIGERATORS & FREEZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 303 NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 304 EUROPE: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 305 ASIA PACIFIC: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 306 LATIN AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 307 MIDDLE EAST: REFRIGERATORS & FREEZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 308 GCC COUNTRIES: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.2.2 Cryostorage systems
    • 6.3.2.2.1 Benefits of long-term preservation of cell cultures to support growth
• TABLE 309 CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 310 NORTH AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 311 EUROPE: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 312 ASIA PACIFIC: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 313 LATIN AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 314 MIDDLE EAST: CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 315 GCC COUNTRIES: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.3.3 OTHER EQUIPMENT
• TABLE 316 OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 317 OTHER EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 318 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 319 EUROPE: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 320 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 321 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 322 MIDDLE EAST: OTHER EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 323 GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3.1 Filtration systems
    • 6.3.3.1.1 Growing use in bioprocessing industry to boost demand
• TABLE 324 LIST OF FILTRATION SYSTEMS, BY KEY PLAYER
• TABLE 325 FILTRATION SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 326 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 327 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 328 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 329 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 330 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 331 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3.2 Cell counters
    • 6.3.3.2.1 Growing adoption of automated cell counters to propel market
• TABLE 332 LIST OF COMMERCIALLY AVAILABLE CELL COUNTERS, BY KEY PLAYER
• TABLE 333 CELL COUNTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 334 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 335 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 336 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 337 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 338 MIDDLE EAST: CELL COUNTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 339 GCC COUNTRIES: CELL COUNTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3.3 Carbon dioxide incubators
    • 6.3.3.3.1 Increasing focus of research institutes on developing lab-scale incubators to drive market
• TABLE 340 CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS
• TABLE 341 CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 342 NORTH AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 343 EUROPE: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 344 ASIA PACIFIC: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 345 LATIN AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 346 MIDDLE EAST: CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 347 GCC COUNTRIES: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3.4 Centrifuges
    • 6.3.3.4.1 Increasing demand for bioproduction applications to drive adoption of centrifuges
• TABLE 348 CENTRIFUGES OFFERED BY KEY MARKET PLAYERS
• TABLE 349 CENTRIFUGES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 350 NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 351 EUROPE: CENTRIFUGES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 352 ASIA PACIFIC: CENTRIFUGES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 353 LATIN AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 354 MIDDLE EAST: CENTRIFUGES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 355 GCC COUNTRIES: CENTRIFUGES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3.5 Autoclaves
    • 6.3.3.5.1 Reliance on single-use labware and equipment to affect demand for autoclaves
• TABLE 356 AUTOCLAVES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 357 NORTH AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 358 EUROPE: AUTOCLAVES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 359 ASIA PACIFIC: AUTOCLAVES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 360 LATIN AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 361 MIDDLE EAST: AUTOCLAVES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 362 GCC COUNTRIES: AUTOCLAVES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3.6 Microscopes
    • 6.3.3.6.1 Inverted microscopes to show sustained demand in cell culture processes
• TABLE 363 MICROSCOPES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 364 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 365 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 366 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 367 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 368 MIDDLE EAST: MICROSCOPES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 369 GCC COUNTRIES: MICROSCOPES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3.7 Biosafety cabinets
    • 6.3.3.7.1 New product launches to drive market
• TABLE 370 BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS
• TABLE 371 BIOSAFETY CABINETS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 372 NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 373 EUROPE: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 374 ASIA PACIFIC: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 375 LATIN AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 376 MIDDLE EAST: BIOSAFETY CABINETS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 377 GCC COUNTRIES: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3.8 Other supporting equipment
• TABLE 378 OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS
• TABLE 379 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 380 NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 381 EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 382 ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 383 LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 384 MIDDLE EAST: OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 385 GCC COUNTRIES: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 CELL CULTURE MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • TABLE 386 CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 7.2 BIOPHARMACEUTICAL PRODUCTION
  • TABLE 387 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 388 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 389 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 390 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 391 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 392 MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 393 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 394 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • 7.2.1 MONOCLONAL ANTIBODY PRODUCTION
    • 7.2.1.1 Increasing approval and launch of mAb candidates to drive growth
  • TABLE 395 CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 396 NORTH AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 397 EUROPE: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 398 ASIA PACIFIC: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 399 LATIN AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 400 MIDDLE EAST: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 401 GCC COUNTRIES: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.2.2 VACCINE PRODUCTION
    • 7.2.2.1 Rising incidence of infectious diseases to support market growth
  • TABLE 402 CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 403 NORTH AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 404 EUROPE: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 405 ASIA PACIFIC: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 406 LATIN AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 407 MIDDLE EAST: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 408 GCC COUNTRIES: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
  • TABLE 409 CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 410 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 411 EUROPE: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 412 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 413 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 414 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 415 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.3 DIAGNOSTICS
  • 7.3.1 ADVANCEMENTS AND ADOPTION OF NEW TECHNIQUES TO DRIVE SEGMENT GROWTH
  • TABLE 416 CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 417 NORTH AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 418 EUROPE: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 419 ASIA PACIFIC: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 420 LATIN AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 421 MIDDLE EAST: CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
  • TABLE 423 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 424 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 425 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 426 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 427 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 428 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 429 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 430 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • 7.4.1 CELL & GENE THERAPY
    • 7.4.1.1 New product launches and strategic alliances to drive segment growth
  • TABLE 431 CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 432 NORTH AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 433 EUROPE: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 434 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 435 LATIN AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 436 MIDDLE EAST: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 437 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.4.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
  • TABLE 438 CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 439 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 440 EUROPE: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 441 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 442 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 443 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 444 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.5 DRUG SCREENING & DEVELOPMENT
  • 7.5.1 INCREASING NEW DRUG DEVELOPMENT ACTIVITIES TO DRIVE MARKET
  • TABLE 445 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 446 NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 447 EUROPE: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 448 ASIA PACIFIC: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 449 LATIN AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 450 MIDDLE EAST: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 451 GCC COUNTRIES: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.6 OTHER APPLICATIONS
  • TABLE 452 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 453 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 454 EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 455 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 456 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 457 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 458 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)

8 CELL CULTURE MARKET, BY END USER

• 8.1 INTRODUCTION
  • TABLE 459 CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD
  • TABLE 460 RECENT DEVELOPMENTS IN PHARMA & BIOTECH SECTOR
  • TABLE 461 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 462 NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 463 EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 464 ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 465 LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 466 MIDDLE EAST: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 467 GCC COUNTRIES: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.3 HOSPITALS & DIAGNOSTIC LABORATORIES
  • 8.3.1 INCREASING DEMAND FOR CELL CULTURE PRODUCTS AND STRATEGIC ACTIVITIES TO DRIVE SEGMENT
  • TABLE 468 CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 469 NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 470 EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 471 ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 472 LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 473 MIDDLE EAST: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 474 GCC COUNTRIES: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.4 RESEARCH & ACADEMIC INSTITUTES
  • 8.4.1 INCREASING FUNDING ACTIVITIES TO DRIVE MARKET
  • TABLE 475 CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 476 NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 477 EUROPE: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 478 ASIA PACIFIC: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 479 LATIN AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 480 MIDDLE EAST: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 481 GCC COUNTRIES: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.5 OTHER END USERS
  • TABLE 482 CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 483 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 484 EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 485 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 486 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 487 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 488 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)

9 CELL CULTURE MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 489 CELL CULTURE MARKET, BY REGION, 2022-2029 (USD MILLION)
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • FIGURE 33 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT
  • TABLE 490 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 491 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 492 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 493 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 494 NORTH AMERICA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 495 NORTH AMERICA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 496 NORTH AMERICA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 497 NORTH AMERICA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 498 NORTH AMERICA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 499 NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 500 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 501 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 502 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 503 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 504 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 505 NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2.2 US
    • 9.2.2.1 US to hold largest share of North American market
  • TABLE 506 INDICATIVE LIST OF CELL AND GENE THERAPIES APPROVED IN 2022
  • TABLE 507 US: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 508 US: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 509 US: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 510 US: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 511 US: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 512 US: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 513 US: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 514 US: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 515 US: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 516 US: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 517 US: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 518 US: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 519 US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 520 US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 521 US: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2.3 CANADA
    • 9.2.3.1 Increasing funding and investments for advancing cell-based therapies to boost market
  • TABLE 522 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 523 CANADA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 524 CANADA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 525 CANADA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 526 CANADA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 527 CANADA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 528 CANADA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 529 CANADA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 530 CANADA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 531 CANADA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 532 CANADA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 533 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 534 CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 535 CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 536 CANADA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.3 EUROPE
  • 9.3.1 EUROPE: RECESSION IMPACT
  • TABLE 537 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 538 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 539 EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 540 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 541 EUROPE: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 542 EUROPE: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 543 EUROPE: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 544 EUROPE: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 545 EUROPE: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 546 EUROPE: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 547 EUROPE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 548 EUROPE: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 549 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 550 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 551 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 552 EUROPE: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.2 GERMANY
    • 9.3.2.1 Rising R&D investments and strategic alliances to drive market
  • TABLE 553 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 554 GERMANY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 555 GERMANY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 556 GERMANY: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 557 GERMANY: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 558 GERMANY: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 559 GERMANY: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 560 GERMANY: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 561 GERMANY: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 562 GERMANY: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 563 GERMANY: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 564 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 565 GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 566 GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 567 GERMANY: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.3 UK
    • 9.3.3.1 Growth in life science industry and favorable government investments to support market
  • TABLE 568 UK: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 569 UK: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 570 UK: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 571 UK: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 572 UK: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 573 UK: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 574 UK: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 575 UK: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 576 UK: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 577 UK: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 578 UK: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 579 UK: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 580 UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 581 UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 582 UK: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)

• 9.3.4 FRANCE
  • 9.3.4.1 Rising number of cell-based research projects to enhance market growth
• TABLE 583 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 584 FRANCE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 585 FRANCE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 586 FRANCE: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 587 FRANCE: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 588 FRANCE: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 589 FRANCE: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 590 FRANCE: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 591 FRANCE: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 592 FRANCE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 593 FRANCE: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 594 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 595 FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 596 FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 597 FRANCE: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.3.5 ITALY
  • 9.3.5.1 Strong government support to enhance R&D activities
• TABLE 598 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 599 ITALY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 600 ITALY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 601 ITALY: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 602 ITALY: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 603 ITALY: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 604 ITALY: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 605 ITALY: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 606 ITALY: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 607 ITALY: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 608 ITALY: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 609 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 610 ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 611 ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 612 ITALY: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.3.6 SPAIN
  • 9.3.6.1 Booming biotechnology industry to aid market growth
• TABLE 613 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 614 SPAIN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 615 SPAIN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 616 SPAIN: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 617 SPAIN: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 618 SPAIN: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 619 SPAIN: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 620 SPAIN: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 621 SPAIN: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 622 SPAIN: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 623 SPAIN: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 624 SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 625 SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 626 SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 627 SPAIN: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.3.7 REST OF EUROPE
• TABLE 628 REST OF EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 629 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 630 REST OF EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 631 REST OF EUROPE: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 632 REST OF EUROPE: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 633 REST OF EUROPE: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 634 REST OF EUROPE: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 635 REST OF EUROPE: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 636 REST OF EUROPE: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 637 REST OF EUROPE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 638 REST OF EUROPE: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 639 REST OF EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 640 REST OF EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 641 REST OF EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 642 REST OF EUROPE: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 34 ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT
  • TABLE 643 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 644 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 645 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 646 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 647 ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 648 ASIA PACIFIC: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 649 ASIA PACIFIC: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 650 ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 651 ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 652 ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 653 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 654 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 655 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 656 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 657 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 658 ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.2 CHINA
    • 9.4.2.1 China to register highest growth rate in Asia Pacific market
  • TABLE 659 CHINA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 660 CHINA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 661 CHINA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 662 CHINA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 663 CHINA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 664 CHINA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 665 CHINA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 666 CHINA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 667 CHINA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 668 CHINA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 669 CHINA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 670 CHINA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 671 CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 672 CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 673 CHINA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.3 JAPAN
    • 9.4.3.1 Rising government initiatives and increasing investments in biotech to drive market
  • TABLE 674 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 675 JAPAN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 676 JAPAN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 677 JAPAN: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 678 JAPAN: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 679 JAPAN: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 680 JAPAN: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 681 JAPAN: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 682 JAPAN: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 683 JAPAN: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 684 JAPAN: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 685 JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 686 JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 687 JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 688 JAPAN: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.4 INDIA
    • 9.4.4.1 Favorable government support and expansion by key cell culture players to augment market growth
  • TABLE 689 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 690 INDIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 691 INDIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 692 INDIA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 693 INDIA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 694 INDIA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 695 INDIA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 696 INDIA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 697 INDIA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 698 INDIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 699 INDIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 700 INDIA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 701 INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 702 INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 703 INDIA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.5 SOUTH KOREA
    • 9.4.5.1 Growing pharmaceutical sector to drive market
  • TABLE 704 SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 705 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 706 SOUTH KOREA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 707 SOUTH KOREA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 708 SOUTH KOREA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 709 SOUTH KOREA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 710 SOUTH KOREA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 711 SOUTH KOREA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 712 SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 713 SOUTH KOREA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 714 SOUTH KOREA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 715 SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 716 SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 717 SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 718 SOUTH KOREA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.6 AUSTRALIA
    • 9.4.6.1 Increasing prevalence of chronic diseases to drive market
  • TABLE 719 AUSTRALIA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 720 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 721 AUSTRALIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 722 AUSTRALIA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 723 AUSTRALIA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 724 AUSTRALIA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 725 AUSTRALIA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 726 AUSTRALIA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 727 AUSTRALIA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 728 AUSTRALIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 729 AUSTRALIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 730 AUSTRALIA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 731 AUSTRALIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 732 AUSTRALIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 733 AUSTRALIA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.7 REST OF ASIA PACIFIC
  • TABLE 734 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 735 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 736 REST OF ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 737 REST OF ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 738 REST OF ASIA PACIFIC: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 739 REST OF ASIA PACIFIC: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 740 REST OF ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 741 REST OF ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 742 REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 743 REST OF ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 744 REST OF ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 745 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 746 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 747 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 748 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.5 LATIN AMERICA
  • 9.5.1 LATIN AMERICA: RECESSION IMPACT
  • TABLE 749 LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 750 LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 751 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 752 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 753 LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 754 LATIN AMERICA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 755 LATIN AMERICA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 756 LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 757 LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 758 LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 759 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 760 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 761 LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 762 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 763 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 764 LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.5.2 BRAZIL
    • 9.5.2.1 Rising prevalence of cancer and related research activities to support market growth
  • TABLE 765 BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 766 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 767 BRAZIL: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 768 BRAZIL: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 769 BRAZIL: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 770 BRAZIL: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 771 BRAZIL: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 772 BRAZIL: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 773 BRAZIL: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 774 BRAZIL: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 775 BRAZIL: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 776 BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 777 BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 778 BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 779 BRAZIL: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.5.3 MEXICO
    • 9.5.3.1 Growth in biopharmaceutical market to spur cell culture demand
  • TABLE 780 MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 781 MEXICO: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 782 MEXICO: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 783 MEXICO: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 784 MEXICO: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 785 MEXICO: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 786 MEXICO: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 787 MEXICO: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 788 MEXICO: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 789 MEXICO: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 790 MEXICO: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 791 MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 792 MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 793 MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 794 MEXICO: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.5.4 REST OF LATIN AMERICA
  • TABLE 795 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 796 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 797 REST OF LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 798 REST OF LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 799 REST OF LATIN AMERICA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 800 REST OF LATIN AMERICA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 801 REST OF LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 802 REST OF LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 803 REST OF LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 804 REST OF LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 805 REST OF LATIN AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 806 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 807 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 808 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 809 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.6 MIDDLE EAST
  • 9.6.1 MIDDLE EAST: RECESSION IMPACT
  • TABLE 810 MIDDLE EAST: CELL CULTURE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 811 MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 812 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 813 MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 814 MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 815 MIDDLE EAST: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 816 MIDDLE EAST: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 817 MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 818 MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 819 MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 820 MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 821 MIDDLE EAST: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 822 MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 823 MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 824 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 825 MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.6.2 GCC COUNTRIES
  • TABLE 826 GCC COUNTRIES: CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 827 GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 828 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 829 GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 830 GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 831 GCC COUNTRIES: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 832 GCC COUNTRIES: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 833 GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 834 GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 835 GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 836 GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 837 GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 838 GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 839 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 840 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 841 GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 9.6.2.1 Saudi Arabia
      • 9.6.2.1.1 Increasing focus of key players on expansion to drive market
  • TABLE 842 SAUDI ARABIA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 843 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 844 SAUDI ARABIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 845 SAUDI ARABIA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 846 SAUDI ARABIA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 847 SAUDI ARABIA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 848 SAUDI ARABIA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 849 SAUDI ARABIA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 850 SAUDI ARABIA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 851 SAUDI ARABIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 852 SAUDI ARABIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 853 SAUDI ARABIA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 854 SAUDI ARABIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 855 SAUDI ARABIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 856 SAUDI ARABIA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 9.6.2.2 UAE
      • 9.6.2.2.1 Developments in healthcare infrastructure and growing government initiatives to drive market
  • TABLE 857 UAE: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 858 UAE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 859 UAE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 860 UAE: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 861 UAE: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 862 UAE: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 863 UAE: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 864 UAE: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 865 UAE: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 866 UAE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 867 UAE: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 868 UAE: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 869 UAE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 870 UAE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 871 UAE: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 9.6.2.3 Rest of GCC Countries
  • TABLE 872 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 873 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 874 REST OF GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 875 REST OF GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 876 REST OF GCC COUNTRIES: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 877 REST OF GCC COUNTRIES: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 878 REST OF GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 879 REST OF GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 880 REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 881 REST OF GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 882 REST OF GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 883 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 884 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 885 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 886 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.6.3 REST OF MIDDLE EAST
  • TABLE 887 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 888 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 889 REST OF MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 890 REST OF MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 891 REST OF MIDDLE EAST: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 892 REST OF MIDDLE EAST: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 893 REST OF MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 894 REST OF MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 895 REST OF MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 896 REST OF MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 897 REST OF MIDDLE EAST: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 898 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 899 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 900 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 901 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.7 AFRICA
  • 9.7.1 RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FUEL MARKET GROWTH
  • 9.7.2 AFRICA: RECESSION IMPACT
  • TABLE 902 AFRICA: CELL CULTURE MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 903 AFRICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 904 AFRICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 905 AFRICA: MEDIA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 906 AFRICA: REAGENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 907 AFRICA: SERA MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 908 AFRICA: VESSELS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 909 AFRICA: EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 910 AFRICA: BIOREACTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 911 AFRICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 912 AFRICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 913 AFRICA: CELL CULTURE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 914 AFRICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 915 AFRICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 916 AFRICA: CELL CULTURE MARKET, BY END USER, 2022-2029 (USD MILLION)

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • TABLE 917 STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, 2022-2024
• 10.3 REVENUE SHARE ANALYSIS
  • FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2019-2023 (USD BILLION)
• 10.4 MARKET SHARE ANALYSIS
  • FIGURE 36 CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • TABLE 918 CELL CULTURE MARKET: DEGREE OF COMPETITION
• 10.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 37 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
  • 10.5.1 THERMO FISHER SCIENTIFIC INC.
  • 10.5.2 DANAHER CORPORATION
  • 10.5.3 MERCK KGAA
  • 10.5.4 SARTORIUS AG
  • 10.5.5 CORNING INCORPORATED
• 10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 10.6.1 STARS
  • 10.6.2 EMERGING LEADERS
  • 10.6.3 PERVASIVE PLAYERS
  • 10.6.4 PARTICIPANTS
  • FIGURE 38 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 10.6.5 COMPANY FOOTPRINT: KEY PLAYERS
  • FIGURE 39 CELL CULTURE MARKET: COMPANY FOOTPRINT
  • TABLE 919 CELL CULTURE MARKET: PRODUCT FOOTPRINT
  • TABLE 920 CELL CULTURE MARKET: APPLICATION FOOTPRINT
  • TABLE 921 CELL CULTURE MARKET: END-USER FOOTPRINT
  • TABLE 922 CELL CULTURE MARKET: REGIONAL FOOTPRINT
• 10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES
  • 10.7.1 PROGRESSIVE COMPANIES
  • 10.7.2 RESPONSIVE COMPANIES
  • 10.7.3 DYNAMIC COMPANIES
  • 10.7.4 STARTING BLOCKS
  • FIGURE 40 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • 10.7.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 923 CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 924 CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
• 10.8 VALUATION AND FINANCIAL METRICS OF CELL CULTURE VENDORS
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES
  • TABLE 925 CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2021-FEBRUARY 2024
  • 10.9.2 DEALS
  • TABLE 926 CELL CULTURE MARKET: DEALS, JANUARY 2021-FEBRUARY 2024
  • 10.9.3 EXPANSIONS
  • TABLE 927 CELL CULTURE MARKET: EXPANSIONS, JANUARY 2021-FEBRUARY 2024

11 COMPANY PROFILES

• 11.1 INTRODUCTION
• 11.2 KEY PLAYERS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
• 11.2.1 THERMO FISHER SCIENTIFIC INC.
• TABLE 928 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
• FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
• TABLE 929 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
• TABLE 930 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
• TABLE 931 THERMO FISHER SCIENTIFIC INC.: DEALS
• TABLE 932 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
• 11.2.2 DANAHER CORPORATION
• TABLE 933 DANAHER CORPORATION: BUSINESS OVERVIEW
• FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT
• TABLE 934 DANAHER CORPORATION: PRODUCTS OFFERED
• TABLE 935 DANAHER CORPORATION: PRODUCT LAUNCHES
• TABLE 936 DANAHER CORPORATION: DEALS
• TABLE 937 DANAHER CORPORATION: EXPANSIONS
• TABLE 938 DANAHER CORPORATION: OTHER DEVELOPMENTS
• 11.2.3 MERCK KGAA
• TABLE 939 MERCK KGAA: BUSINESS OVERVIEW
• FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT
• TABLE 940 MERCK KGAA: PRODUCTS OFFERED
• TABLE 941 MERCK KGAA: PRODUCT LAUNCHES
• TABLE 942 MERCK KGAA: DEALS
• TABLE 943 MERCK KGAA: EXPANSIONS
• 11.2.4 SARTORIUS AG
• TABLE 944 SARTORIUS AG: BUSINESS OVERVIEW
• FIGURE 46 SARTORIUS AG: COMPANY SNAPSHOT
• TABLE 945 SARTORIUS AG: PRODUCTS OFFERED
• TABLE 946 SARTORIUS AG: PRODUCT LAUNCHES
• TABLE 947 SARTORIUS AG: DEALS
• TABLE 948 SARTORIUS AG: EXPANSIONS
• 11.2.5 CORNING INCORPORATED
• TABLE 949 CORNING INCORPORATED: BUSINESS OVERVIEW
• FIGURE 47 CORNING INCORPORATED: COMPANY SNAPSHOT
• TABLE 950 CORNING INCORPORATED: PRODUCTS OFFERED
• TABLE 951 CORNING INCORPORATED: PRODUCT LAUNCHES
• TABLE 952 CORNING INCORPORATED: DEALS
• 11.2.6 FUJIFILM HOLDINGS CORPORATION
• TABLE 953 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
• FIGURE 48 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
• TABLE 954 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
• TABLE 955 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES
• TABLE 956 FUJIFILM HOLDINGS CORPORATION: DEALS
• TABLE 957 FUJIFILM HOLDINGS CORPORATION: EXPANSIONS
• 11.2.7 BD
• TABLE 958 BD: BUSINESS OVERVIEW
• FIGURE 49 BD: COMPANY SNAPSHOT
• TABLE 959 BD: PRODUCTS OFFERED
• TABLE 960 BD: PRODUCT LAUNCHES
• TABLE 961 BD: DEALS
• 11.2.8 EPPENDORF SE
• TABLE 962 EPPENDORF SE: BUSINESS OVERVIEW
• FIGURE 50 EPPENDORF SE: COMPANY SNAPSHOT
• TABLE 963 EPPENDORF SE: PRODUCTS OFFERED
• TABLE 964 EPPENDORF SE: PRODUCT LAUNCHES
• TABLE 965 EPPENDORF SE: DEALS
• TABLE 966 EPPENDORF SE: EXPANSIONS
• 11.2.9 LONZA
• TABLE 967 LONZA: BUSINESS OVERVIEW
• FIGURE 51 LONZA: COMPANY SNAPSHOT
• TABLE 968 LONZA: PRODUCTS OFFERED
• TABLE 969 LONZA: PRODUCT LAUNCHES
• TABLE 970 LONZA: DEALS
• 11.2.10 GETINGE AB
• TABLE 971 GETINGE AB: BUSINESS OVERVIEW
• FIGURE 52 GETINGE AB: COMPANY SNAPSHOT
• TABLE 972 GETINGE AB: PRODUCTS OFFERED
• TABLE 973 GETINGE AB: PRODUCT LAUNCHES
• TABLE 974 GETINGE AB: DEALS
• TABLE 975 GETINGE AB: EXPANSIONS
• 11.2.11 AGILENT TECHNOLOGIES, INC.
• TABLE 976 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
• FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
• TABLE 977 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
• TABLE 978 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
• TABLE 979 AGILENT TECHNOLOGIES, INC.: DEALS
• 11.2.12 HIMEDIA LABORATORIES
• TABLE 980 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
• TABLE 981 HIMEDIA LABORATORIES: PRODUCTS OFFERED
• 11.2.13 BIO-TECHNE
• TABLE 982 BIO-TECHNE: COMPANY OVERVIEW
• FIGURE 54 BIO-TECHNE: COMPANY SNAPSHOT
• TABLE 983 BIO-TECHNE: PRODUCTS OFFERED
• TABLE 984 BIO-TECHNE: PRODUCT LAUNCHES
• TABLE 985 BIO-TECHNE: DEALS
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies
• 11.3 OTHER PLAYERS
• 11.3.1 MILTENYI BIOTEC
• TABLE 986 MILTENYI BIOTEC: BUSINESS OVERVIEW
• 11.3.2 STEMCELL TECHNOLOGIES0
• TABLE 987 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW
• 11.3.3 SOLIDA BIOTECH GMBH
• TABLE 988 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
• 11.3.4 CAISSON LABS INC.
• TABLE 989 CAISSON LABS INC.: BUSINESS OVERVIEW
• 11.3.5 PROMOCELL GMBH
• TABLE 990 PROMOCELL GMBH: BUSINESS OVERVIEW
• 11.3.6 INVIVOGEN
• TABLE 991 INVIVOGEN: BUSINESS OVERVIEW
• 11.3.7 PAN-BIOTECH
• TABLE 992 PAN-BIOTECH: BUSINESS OVERVIEW
• 11.3.8 CELLEXUS
• TABLE 993 CELLEXUS: BUSINESS OVERVIEW
• 11.3.9 MEISSNER FILTRATION PRODUCTS, INC.
• TABLE 994 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW
• 11.3.10 ADOLF KUHNER AG
• TABLE 995 ADOLF KUHNER AG: BUSINESS OVERVIEW
• 11.3.11 ADVANCION CORPORATION
• TABLE 996 ADVANCION CORPORATION: BUSINESS OVERVIEW
• 11.3.12 BIOSPHERIX, LTD.
• TABLE 997 BIOSPHERIX, LTD.: BUSINESS OVERVIEW

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

관련자료